BIO-Europe: Pareto Securities' Biotech Analyst Dan Akschuti shares his thoughts on the conference and discusses recent company successes in the nordic region
He says there has been an upswing in investors looking at companies. Plus, his thoughts on BioInvent, Oculis, and Camurus.
Brought to you by